September 2001
1145
Table 7. 1H–NMR Spectrum Data of Tripeptide Derivatives (Boc-A3–A2–A1-OBzl)
A3–A2–A1
Solvent
Chemical shift (200 MHz) : d (ppm)
Lys–Pro–Leu
DMSO–d6
0.82 (3H, d, Jϭ6.2 Hz), 0.89 (3H, d, Jϭ6.2 Hz), 1.37 (9H, s), 1.47—1.89 (16H, m),
3.00 (2H, d, Jϭ3.4 Hz), 3.37—3.70 (2H, m), 4.01—4.39 (2H, m), 5.02 (2H, s), 5.01 (2H, d, Jϭ2.6 Hz),
6.90 (1H, d, Jϭ7.8 Hz), 7.25—7.45 (10H, m), 8.24 (1H, d, Jϭ7.8 Hz)
Lys–Pro–Ser
Tyr–Pro–Lys
Trp–Pro–Lys
Ser–Lys–Pro
Arg–Lys–Glu
CDCl3
CDCl3
CDCl3
CDCl3
CDCl3
1.26—2.21 (18H, m), 3.12 (2H, d, Jϭ5.4 Hz), 3.54—3.74 (4H, m), 4.41 (2H, d, Jϭ8.6 Hz),
4.50—4.88 (3H, m), 5.05 (2H, s), 5.14 (2H, d, Jϭ10.4 Hz), 5.21—5.48 (2H,m), 6.96 (1H, d, Jϭ8.4 Hz),
7.19—7.42 (15H, m)
1.25—1.49 (15H, m), 1.88—2.15 (2H, m), 2.68—2.98 (2H, m), 3.10—3.75 (3H, m),
4.34—4.68 (3H, m), 5.01 (2H, s), 5.05—5.15 (2H,m), 5.17 (2H, d, Jϭ4.2 Hz), 5.59 (1H, d, Jϭ8.4 Hz),
5.81 (1H, s), 6.75—7.10 (5H, m), 7.30—7.44 (16H, m)
1.23—1.51 (15H, m), 1.78—2.18 (4H, m), 2.95—3.65 (6H, m), 4.39—4.41 (1H, m),
4.49—4.61 (1H, m), 4.71—4.85 (1H, m), 5.05—5.25 (4H,m), 5.58—5.75 (1H, m),
6.89—7.20 (16H, m), 7.68 (1H, d, Jϭ4.2 Hz), 8.56 (1H, s)
1.43 (9H, s), 1.48—1.74 (6H, m), 1.88—2.28 (4H, m), 3.11 (2H, d, Jϭ5.4 Hz),
3.53—3.78 (4H, m), 3.92—3.98 (1H, m), 4.21—4.35 (1H, m), 4.50 (2H, s), 4.57 (1H, d, Jϭ4.6 Hz),
4.75 (1H, d, Jϭ4.6 Hz), 5.07 (2H, s), 5.10—5.45 (3H, m), 7.30—7.44 (15H, m)
1.23—1.56 (24H, m), 1.78—2.02 (6H, m), 2.25—2.40 (3H, m), 3.05—3.25 (4H, m),
4.28—4.41 (1H, m), 4.45—4.61 (1H, m), 4.62—4.78 (1H, m), 5.06 (2H, s), 5.08 (2H, d, Jϭ4.8 Hz),
5.21—5.32 (1H, m), 5.45—5.53 (1H, d, Jϭ4.8 Hz), 6.38 (2H, br s), 7.20 (2H, d, Jϭ6.2 Hz),
7.32 (12H, s), 7.75 (2H, d, Jϭ6.2 Hz)
Trp–Lys–Pro
Ala–Lys–His
Leu–Tyr–Pro
Glu–Tyr–Trp
Ser–Tyr–His
His–Tyr–Lys
CDCl3
CDCl3
CDCl3
CDCl3
CDCl3
CDCl3
1.23—1.56 (4H, m), 1.43 (9H, s), 1.84—2.23 (4H, m), 2.96—3.20 (3H, m), 3.36—3.62 (3H, m),
4.35—4.41 (1H, s), 4.43 (1H, d, Jϭ4.8 Hz), 4.50—4.66 (1H, m), 5.04 (2H, m),
5.11—5.18 (2H, d, Jϭ4.8 Hz), 5.12 (2H, s), 6.42 (1H, d, Jϭ4.8 Hz), 6.72—6.86 (1H, d, Jϭ6.2 Hz),
7.04—7.39 (13H, m), 7.57 (1H, d, Jϭ7.2 Hz), 9.12 (1H, s)
1.27 (3H, d, Jϭ4.6 Hz), 1.15—1.78 (6H,m), 1.42 (9H, s), 3.18 (2H, t, Jϭ4.4 Hz),
4.11 (1H, t, Jϭ4.8 Hz), 4.33 (1H, t, Jϭ4.8 Hz), 4.37 (2H, s), 4.90 (1H, q, Jϭ4.8 Hz),
5.08 (2H, s), 5.10 (2H, s), 5.02—5.30 (2H, m), 5.21 (2H, s), 6.78 (1H, s), 6.78 (1H, d, Jϭ4.2 Hz),
7.22—7.42 (16H, m)
0.90 (6H, d, Jϭ5.2 Hz), 1.43 (9H, s), 1.48—2.23 (8H, m), 2.80—3.21 (3H, m),
3.45—3.58 (1H, m), 4.48—4.58 (2H, m), 4.61—4.92 (2H, m), 5.02 (2H, s), 5.01—5.15 (1H, m),
5.20 (2H, s), 6.72 (1H, d, Jϭ4.8 Hz), 6.85 (2H, d, Jϭ7.8 Hz), 7.14 (2H, d, Jϭ7.8 Hz),
7.28—7.48 (10H, m), 6.78 (1H, d, Jϭ4.2 Hz), 7.22—7.42 (16H, m)
1.21—1.85 (4H, m), 1.42 (9H, s), 2.22—2.34 (2H, m), 2.94 (2H, d, Jϭ6.6 Hz),
3.33 (2H, d, Jϭ6.6 Hz), 3.92—4.08 (1H, m), 4.51—4.96 (3H, m), 5.00 (2H, s),
5.06 (2H, s), 6.39—6.43 (1H, m), 6.61 (1H, d, Jϭ8.4 Hz), 6.71 (1H, s), 6.82 (2H, d, Jϭ8.4 Hz),
7.06 (2H, d, Jϭ8.4 Hz), 7.28—7.46 (12H, m), 8.31 (1H, br s)
1.43 (9H, s), 2.98 (2H, d, Jϭ6.6 Hz), 3.08 (2H, d, Jϭ6.6 Hz), 3.61—3.78 (1H, m),
3.82—3.98 (1H, m), 4.21—4.40 (1H, m), 4.39 (2H, s), 4.55 (2H, s), 4.58—4.70 (1H, m),
4.82—4.95 (1H, m) 5.02 (2H, s), 5.15 (2H, s), 5.25 (2H, s), 5.39 (1H, d, Jϭ4.8 Hz),
6.77—7.04 (7H, m), 7.31—7.51 (21H, m)
1.15—1.85 (6H, m), 1.39 (9H, s), 2.80—3.20 (6H, m), 4.32—4.58 (3H, m), 4.47 (2H, s),
4.97 (2H, s), 5.08 (2H, s), 5.12 (2H, s), 5.19 (2H, brs), 5.29—5.41 (1H, m),
5.85—5.99 (1H, s), 6.35 (1H, d, Jϭ8.4 Hz), 6.55 (1H, m), 6.82 (2H, d, Jϭ8.6 Hz),
6.99 (2H, d, Jϭ8.6 Hz), 7.27—7.46 (23H, m)
Table 8. Improvement and Merits of the MSA Method
Industries Ltd., and the starting amino acid derivatives were commercially
available reagents from Peptide Institute Inc. Column chromatography was
carried out on Silica Gel 60 (70—230 mesh, ASTM, Merck). The starting
dipeptides (27 kinds) were synthesized in our large-scale automated synthe-
sis apparatus (FUTOSHI).11) Typical synthesis for one dipeptide, Boc-
Pro–Ala-OBzl, was as follows: In a 2 l three-necked flask, MSA (98 g) in
acetonitrile (600 ml) was added to Boc-Ala-OBzl (112 g, 400 mmol) in ace-
tonitrile (400 ml) at room temperature and the reaction mixture was stirred
for 1 h. After the reaction mixture was cooled to 0 °C, diisopropylethylamine
(78.6 g, 600 mmol) was added, and then Boc-Pro (86.1 g, 400 mmol), HOBt
(67.4 g, 440 mmol), and WSCD (68.4 g, 440 mmol) in acetonitrile (100 ml)–
DMF (200 ml) was added. After the reaction mixture was stirred for 16 h,
solvents were evaporated-off, and the residue was extracted from ethyl ac-
etate–5% sodium hydrogen carbonate, and washed with 0.2 N hydrochloric
acid and water. The organic layer was dried, and evaporated, and recrystal-
lized from diisopropylether affording 124.6 g (83%) of the expected product.
General Procedure of Peptide Bond Formation The procedure for
Improvement
Effect (Merit)
Avoid use of trifluoroacetic acid
(volatile, corrosive acid)
Easy handling and less damage
to the apparatus
Avoid use of dichloromethane
Friendly to the environment
Decrease of the number of extractions Increased reliability
and drying processes
(ca. 90%→ca. 99%)
Generation of the free amine and
activated ester at the same time
Higher yield (70.1→77.4%)
Easy set up and simpler process
Higher throughput
Experimental
Computer-controlled automated synthesis systems (TAFT, EASY, peptide bond formation between Boc-Leu and Boc-Pro–Lys(Z)-OBzl is de-
ASTRO)10) were used to synthesize oligopeptide derivatives in solution. Op- scribed as a typical example. Table 2 lists the subroutine sequence by which
tical rotation values (in MeOH) were measured with a Nihon Bunko DIP-
the apparatus was controlled. In the reaction flask1 (RF1), to a powder of
370 spectrometer. All melting points were taken with a Yanagimoto micro Boc-Pro–Lys(Z)-OBzl (1.70 g, 3.0 mmol) was added MSA in acetonitrile
melting point apparatus and are uncorrected. NMR spectra were measured (12 ml, 12 mmol) from reagent reservoir 2 (RR2) [RF1-ST-ON, RR2-RF1].
on a Varian Gemini-200 or a JOEL JNM-GX400 FT NMR spectrometer (in Then the reaction mixture was stirred at 40 °C for 1 h [RF1-LF-UP, REA1
CDCl3). Solvents were of special or first grade from Wako Pure Chemical (40c, 60 m)]. The solution was cooled to 0 °C, and ethyldiisopropylamine in